🇺🇸 FDA
Patent

US 7893087

Quinuclidine derivatives and medicinal compositions containing the same

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7893087 (Quinuclidine derivatives and medicinal compositions containing the same) held by Almirall, S.A. expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P13/00